Cooperation

Xavier Tekpli, Project group leader, Researcher; PhD OUH - Breast Cancer Heterogeneity and Oncoimmunology (ous-research.no)
Professor, Group leader Jürgen Geisler, UiO and Ahus Jürgen Geisler - Institutt for klinisk medisin (uio.no) Translasjonell kreftforskning, Ahus - Institutt for klinisk medisin (uio.no)
Professor, Group leader Vessela N. Kristensen, Ullevål universitetssykehus, OUS OUH - Cancer Genome Variation (ous-research.no)
Øystein Garred, MD, PhD, Dep. of Pathology, Ullevål universitetssykehus, OUS
Leonardo Meza-Zepeda, PhD, Project leader of Translational Genomics group, Head of the HSØ and University of Oslo Genomics Core Facility, and Head of the Department of Core Facilities at the Institute for Cancer Research, OUS OUH - Translational Genomics (ous-research.no)
Stefano Ferrari, PhD, Head of the Research Centre of the Veneto Eye Bank Foundation (FBOV; http://research.fbov.org).
Marina Bertolin, Researcher at the Research Centre of the Veneto Eye Bank Foundation (FBOV; http://research.fbov.org).
Roger Olofsson Bagge, Professor, Senior consultant surgeon and Group leader at Sahlgrenska Center for Cancer Research and The Wallenberg Center for Molecular and Translational Medicine Group Roger Olofsson Bagge | University of Gothenburg (gu.se)
Rossella Crescitelli, PhD, Assistant Professor, University of Gothenburg, Sahlgrenska Center for Cancer Research, Sweden. Group Rossella Crescitelli | University of Gothenburg
Lars Ny , MD PhD, Professor/ Chief Physician, Deputy Head of Department, Department of Oncology, Institute of Clinical Sciences , University of Gothenburg.
Kulbhushan Sharma, PhD, Leader Stem cell facility, Senior Researcher and PI, Epigen, Akershus University Hospital/UiO, Lørenskog, Norway.
Tarjei Sveinsgjerd Hveem, PhD Institute Leader, Institute for Cancer Genetics and Informatics, Oslo University Hospital.
Andreas Kleppe, PhD, Research Leader, Institute for Cancer Genetics and Informatics, Oslo University Hospital & Associate Professor, Department of Informatics, University of Oslo.
Francesca Micci, PhD, Head of the Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital